Friend or foe? The elusive role of hepatic stellate cells in liver cancer

B Cogliati, CN Yashaswini, S Wang, D Sia… - Nature Reviews …, 2023 - nature.com
Liver fibrosis is a substantial risk factor for the development and progression of liver cancer,
which includes hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma …

Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD)

CM Flessa, I Kyrou, N Nasiri‐Ansari… - Journal of Cellular …, 2022 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic fat accumulation in the
absence of excessive alcohol consumption and is strongly associated with obesity, type 2 …

New insights and potential therapeutic interventions in metabolic diseases

VJ Clemente-Suárez, A Martín-Rodríguez… - International Journal of …, 2023 - mdpi.com
Endocrine homeostasis and metabolic diseases have been the subject of extensive
research in recent years. The development of new techniques and insights has led to a …

Response to contamination of isolated mouse Kupffer cells with liver sinusoidal endothelial cells

M Iannacone, C Blériot, F Andreata, X Ficht, C Laura… - Immunity, 2022 - cell.com
The letter from Hume et al.(2022) argues that the discrete subpopulation of Kupffer cells
(KCs), ie, the liver resident macrophages, that we recently described and named KC2 …

Inflammatory and immune etiology of type 2 diabetes

C Blériot, É Dalmas, F Ginhoux, N Venteclef - Trends in Immunology, 2023 - cell.com
Abstract Type 2 diabetes (T2D) represents a global threat affecting millions of patients
worldwide. However, its causes remain incompletely dissected and we lack the tools to …

Single-cell metabolic profiling reveals subgroups of primary human hepatocytes with heterogeneous responses to drug challenge

E Sanchez-Quant, ML Richter, M Colomé-Tatché… - Genome Biology, 2023 - Springer
Background Xenobiotics are primarily metabolized by hepatocytes in the liver, and primary
human hepatocytes are the gold standard model for the assessment of drug efficacy, safety …

Cellular heterogeneity and plasticity during NAFLD progression

HJ Park, J Choi, H Kim, DY Yang, TH An… - Frontiers in Molecular …, 2023 - frontiersin.org
Nonalcoholic fatty liver disease (NAFLD) is a progressive liver disease that can progress to
nonalcoholic steatohepatitis (NASH), NASH-related cirrhosis, and hepatocellular carcinoma …

Interplay between GH-regulated, sex-biased liver transcriptome and hepatic zonation revealed by single-nucleus RNA sequencing

CN Goldfarb, K Karri, M Pyatkov, DJ Waxman - Endocrinology, 2022 - academic.oup.com
The zonation of liver metabolic processes is well-characterized; however, little is known
about the cell type-specificity and zonation of sexually dimorphic gene expression or its …

An innate granuloma eradicates an environmental pathogen using Gsdmd and Nos2

CK Harvest, TJ Abele, C Yu, CJ Beatty… - Nature …, 2023 - nature.com
Granulomas often form around pathogens that cause chronic infections. Here, we discover
an innate granuloma model in mice with an environmental bacterium called …

LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease

J Lee, H Kim, YW Kang, Y Kim, M Park… - … & Molecular Medicine, 2023 - nature.com
Nonalcoholic fatty liver disease (NAFLD) is a serious metabolic disorder characterized by
excess fat accumulation in the liver. Over the past decade, NAFLD prevalence and …